Featured Research

from universities, journals, and other organizations

Chemotherapy And Radiation Together May Help Lung Cancer Patients Live Longer

Date:
September 13, 2000
Source:
Thomas Jefferson University
Summary:
Non-small cell lung cancer (NSCLC) - the kind related mostly to smoking - is terribly difficult to treat. Now, researchers at Jefferson Medical College of Thomas Jefferson University have clinical trial results showing that giving advanced lung cancer patients a common chemotherapy drug at the same time they receive daily radiation may help them live longer than by taking one treatment at a time.

Findings may change the treatment for thousands

Non-small cell lung cancer (NSCLC) - the kind related mostly to smoking - is terribly difficult to treat. Now, researchers at Jefferson Medical College of Thomas Jefferson University have clinical trial results showing that giving advanced lung cancer patients a common chemotherapy drug at the same time they receive daily radiation may help them live longer than by taking one treatment at a time. The new findings promise to change the way thousands of lung cancer patients are treated.

"It's a major step both in patient care and for the future of this particular regimen of chemotherapy and radiation for non-small cell lung cancer," says Walter J. Curran, Jr., M.D., professor and chair of radiation oncology at Jefferson Medical College of Thomas Jefferson University in Philadelphia and clinical director of Jefferson's Kimmel Cancer Center. "With this study, we know that many patients can safely take this regimen.

"This is an important story in drug development because in order for a drug to be used for this stage of the disease, it has to be well tolerated when given with ionizing radiation," he says. "Not all cancer drugs can be combined safely with radiation."

Dr. Curran, who is chairman of the Radiation Therapy Oncology Group, a federally funded cancer clinical trials group which carries out multi-disciplinary research nationwide and which conducted the trial, presents his team's findings Sept. 12 in Tokyo at the Congress of the International Association for the Study of Lung Cancer.

Dr. Curran, along with colleagues at Fox Chase Cancer Center in Philadelphia, M.D. Anderson Cancer Center in Houston and several other centers, examined the results of 597 patients treated with concurrent chemotherapy and daily chest radiation. They found that on average, patients who received the concurrent treatment lived 17.1 months. Those treated sequentially lived an average of 14.6 months.

"Keep in mind that the studies published 10 years ago showed patient survival of 10 months. Now this study is showing a median survival time of 17 months, which is quite an improvement," says Dr. Curran. "The percentage of patients alive at five years or greater increases as well. The median follow up in the study is now over four years. We're seeing substantial numbers of patients five years or later after treatment, which was infrequently seen in a disease that is the most common cause of cancer-related death in this country and worldwide. When you go from 14 to 17 months in median survival time, that's a substantial improvement."

Locally advanced non-small cell lung cancer is diagnosed annually in approximately 50,000 Americans. Nearly all NSCLC cases - which make up approximately 75 percent of lung cancer - are smoking-related. NSCLC tends to spread to adjacent lymph nodes. Surgery offers little to such patients, leaving radiation and chemotherapy.

Patients in the current study were assigned to one of three arms. Patients in arm one received the standard sequential chemotherapy and chest radiation. Those in arm two received daily radiation along with two drugs - cisplatin and vinblastine - at different times in the therapy. In arm three, patients were given a slightly different schedule of the chemotherapy, along with radiation therapy twice daily.

"We conclude that there may be an advantage to concurrent therapy, but there doesn't appear to be an advantage with twice a day radiation," Dr. Curran says. "This study provides strong support for continuing to investigate chemotherapy and radiation delivered concurrently." Patients did experience an increase in side effects, such as difficulty swallowing and bone marrow suppression and anemia.

This is the second major study in the world to look at this issue. A Japanese study also showed 14 months median survival with sequential therapy and 17 months with concurrent treatment, says Dr. Curran.

"Previous studies have shown a five-year survival rate of 5 percent patients with locally advanced NSCLC," he explains. Today, with combining chemotherapy and radiation treatments, 18 percent or more of patients may live five years. "This is a much greater increase in survival rates, percentage-wise, than has been seen in many other major cancers," he says.

He points out that over the last 12 years, researchers have been able to help patients more than double their chance of long-term survival. "When you consider what a common disease this is, doubling the five-year survival rate is a substantial benefit."


Story Source:

The above story is based on materials provided by Thomas Jefferson University. Note: Materials may be edited for content and length.


Cite This Page:

Thomas Jefferson University. "Chemotherapy And Radiation Together May Help Lung Cancer Patients Live Longer." ScienceDaily. ScienceDaily, 13 September 2000. <www.sciencedaily.com/releases/2000/09/000913083204.htm>.
Thomas Jefferson University. (2000, September 13). Chemotherapy And Radiation Together May Help Lung Cancer Patients Live Longer. ScienceDaily. Retrieved September 15, 2014 from www.sciencedaily.com/releases/2000/09/000913083204.htm
Thomas Jefferson University. "Chemotherapy And Radiation Together May Help Lung Cancer Patients Live Longer." ScienceDaily. www.sciencedaily.com/releases/2000/09/000913083204.htm (accessed September 15, 2014).

Share This



More Health & Medicine News

Monday, September 15, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Respiratory Virus Spreads To Northeast, Now In 21 States

Respiratory Virus Spreads To Northeast, Now In 21 States

Newsy (Sep. 14, 2014) The respiratory virus Enterovirus D68, which targets children, has spread from the Midwest to 21 states. Video provided by Newsy
Powered by NewsLook.com
Shocker: Journalists Are Utterly Addicted To Coffee

Shocker: Journalists Are Utterly Addicted To Coffee

Newsy (Sep. 13, 2014) A U.K. survey found that journalists consumed the most amount of coffee, but that's only the tip of the coffee-related statistics iceberg. Video provided by Newsy
Powered by NewsLook.com
Contagious Respiratory Illness Continues to Spread Across U.S.

Contagious Respiratory Illness Continues to Spread Across U.S.

Reuters - US Online Video (Sep. 12, 2014) Hundreds of children in several states have been stricken by a serious respiratory illness that is spreading across the U.S. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Batters Sierra Leone Economy Too

Ebola Batters Sierra Leone Economy Too

Reuters - Business Video Online (Sep. 12, 2014) The World Health Organisation warns that local health workers in West Africa can't keep up with Ebola - and among those countries hardest hit by the outbreak, the economic damage is coming into focus, too. As David Pollard reports, Sierra Leone admits that growth in one of the poorest economies in the region is taking a beating. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins